These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 22504459
21. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin. Bitan M, Mohsen M, Levi E, Wygoda MR, Miao HQ, Lider O, Svahn CM, Ekre HP, Ishai-Michaeli R, Bar-Shavit R. Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578 [Abstract] [Full Text] [Related]
22. Interactions of oversulfated chondroitin sulfate (OSCS) from different sources with unfractionated heparin. Gray A, Litinas E, Jeske W, Fareed J, Hoppensteadt D. Clin Appl Thromb Hemost; 2012; 18(2):166-73. PubMed ID: 22311630 [Abstract] [Full Text] [Related]
23. Fucosylated chondroitin sulfate as a new oral antithrombotic agent. Fonseca RJ, Mourão PA. Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379 [Abstract] [Full Text] [Related]
24. Structural and hemostatic activities of a sulfated galactofucan from the brown alga Spatoglossum schroederi. An ideal antithrombotic agent? Rocha HA, Moraes FA, Trindade ES, Franco CR, Torquato RJ, Veiga SS, Valente AP, Mourão PA, Leite EL, Nader HB, Dietrich CP. J Biol Chem; 2005 Dec 16; 280(50):41278-88. PubMed ID: 16174777 [Abstract] [Full Text] [Related]
25. Experimental studies on the relative efficacy of dermatan sulphate and heparin as antithrombotic agents. Merton RE, Thomas DP. Thromb Haemost; 1987 Oct 28; 58(3):839-42. PubMed ID: 3433248 [Abstract] [Full Text] [Related]
26. Differential effect of the low-molecular-weight heparin, dalteparin, and unfractionated heparin on microvascular endothelial cell hemostatic properties. Vignoli A, Marchetti M, Balducci D, Barbui T, Falanga A. Haematologica; 2006 Feb 28; 91(2):207-14. PubMed ID: 16461305 [Abstract] [Full Text] [Related]
27. A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next? Petitou M, van Boeckel CA. Angew Chem Int Ed Engl; 2004 Jun 14; 43(24):3118-33. PubMed ID: 15199558 [Abstract] [Full Text] [Related]
28. The relative antithrombotic effectiveness of heparin, a low molecular weight heparin, and a pentasaccharide fragment in an animal model. Thomas DP, Merton RE, Gray E, Barrowcliffe TW. Thromb Haemost; 1989 Apr 25; 61(2):204-7. PubMed ID: 2546282 [Abstract] [Full Text] [Related]
29. Inhibition of B16-BL6 melanoma lung colonies by semisynthetic sulfaminoheparosan sulfates from E. coli K5 polysaccharide. Poggi A, Rossi C, Casella N, Bruno C, Sturiale L, Dossi C, Naggi A. Semin Thromb Hemost; 2002 Aug 25; 28(4):383-92. PubMed ID: 12244486 [Abstract] [Full Text] [Related]
30. Antithrombotic and anticoagulant activity of depolymerized fragment of the glycosaminoglycan extracted from Stichopus japonicus Selenka. Suzuki N, Kitazato K, Takamatsu J, Saito H. Thromb Haemost; 1991 Apr 08; 65(4):369-73. PubMed ID: 1647552 [Abstract] [Full Text] [Related]
31. [The effect of the joint administration of heparin and chitosan sulfate ether on hemostatic function]. Drozd NN, Makarov VA, Bashkov GV, Gal'braĭkh LS, Vikhoreva GA, Gorbacheva IN. Eksp Klin Farmakol; 1996 Apr 08; 59(1):30-3. PubMed ID: 8704629 [Abstract] [Full Text] [Related]
32. Antithrombin III-independent effect of depolymerized holothurian glycosaminoglycan (DHG) on acute thromboembolism in mice. Nagase H, Kitazato KT, Sasaki E, Hattori M, Kitazato K, Saito H. Thromb Haemost; 1997 Feb 08; 77(2):399-402. PubMed ID: 9157603 [Abstract] [Full Text] [Related]
33. Experimental studies on the antithrombotic and haemorrhagic effects of heparin and a low molecular weight heparin derivative. Kaiser B, Hauptmann J, Markwardt F. Folia Haematol Int Mag Klin Morphol Blutforsch; 1988 Feb 08; 115(1-2):119-25. PubMed ID: 2459005 [Abstract] [Full Text] [Related]
34. Slight differences in sulfation of algal galactans account for differences in their anticoagulant and venous antithrombotic activities. Fonseca RJ, Oliveira SN, Melo FR, Pereira MG, Benevides NM, Mourão PA. Thromb Haemost; 2008 Mar 08; 99(3):539-45. PubMed ID: 18327402 [Abstract] [Full Text] [Related]
35. Clinical efficacy of heparin fractions: issues and answers. Messmore HL. Crit Rev Clin Lab Sci; 1986 Mar 08; 23(2):77-94. PubMed ID: 2419035 [Abstract] [Full Text] [Related]
36. Pharmacologic properties of an unfractionated heparin butyryl derivative with long-lasting effects. Saivin S, Petitou M, Lormeau JC, Dupouy D, Sie P, Caranobe C, Houin G, Boneu B. J Lab Clin Med; 1992 Feb 08; 119(2):189-96. PubMed ID: 1740633 [Abstract] [Full Text] [Related]
37. Antithrombin III affinity dependence on the anticoagulant, antiprotease, and tissue factor pathway inhibitor actions of heparins. Jeske W, Lormeau JC, Callas D, Iqbal O, Hoppensteadt D, Fareed J. Semin Thromb Hemost; 1995 Feb 08; 21(2):193-200. PubMed ID: 7660142 [Abstract] [Full Text] [Related]
38. Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro. Collen A, Smorenburg SM, Peters E, Lupu F, Koolwijk P, Van Noorden C, van Hinsbergh VW. Cancer Res; 2000 Nov 01; 60(21):6196-200. PubMed ID: 11085545 [Abstract] [Full Text] [Related]
39. Development of new heparin-like compounds and other antithrombotic drugs and their interaction with vascular endothelial cells. Nader HB, Pinhal MA, Baú EC, Castro RA, Medeiros GF, Chavante SF, Leite EL, Trindade ES, Shinjo SK, Rocha HA, Tersariol IL, Mendes A, Dietrich CP. Braz J Med Biol Res; 2001 Jun 01; 34(6):699-709. PubMed ID: 11378657 [Abstract] [Full Text] [Related]
40. Modulation of vascular human endothelial and rat smooth muscle cell growth by a fucosylated chondroitin sulfate from echinoderm. Tapon-Bretaudière J, Drouet B, Matou S, Mourão PA, Bros A, Letourneur D, Fischer AM. Thromb Haemost; 2000 Aug 01; 84(2):332-7. PubMed ID: 10959709 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]